IBN receives patent approval for eriocitrin to support blood glucose management

Excerpt from NutritionInsight.com

Ingredients by Nature (IBN) has gained patent approval for the use of eriocitrin in its ingredient formulations, including Eriomin.

"Supported by a successful first clinical trial and now this patent, our line of Eriomin lemon flavonoid blends provide powerful support to managing healthy blood glucose levels," said Rob Brewster, president of IBN.

Read more about the patent and Eriomin on NutritionInsight.com ยป